$13.850
+0.906 (+6.54%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SNSE Prediction & Forecast by Similar Chart Analysis
Alphio's SNSE stock price prediction model matches the current Faeth Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.99 (+1.01%). The 1-week path is $13.73 (-0.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Faeth Therapeutics, Inc Stock?
SNSE is not a good buy right now for a Beginner investor focused on long-term holding. The stock is showing short-term oversold conditions and there is fresh bullish analyst coverage, but there is no proprietary buy signal, no supportive financial snapshot, and insider selling is rising sharply. Given the clinical-stage biotech profile and the lack of confirmed momentum or fundamentals in the provided data, the better call is to wait rather than buy aggressively today.
SNSE stock price ended at $13.85 on Monday, after rising +6.54%
Faeth Therapeutics, Inc (SNSE) last closed at $13.85, gaining +6.54%. These facts feed the 1-day and 1-week SNSE price prediction above.
Forecast Drivers
Faeth Therapeutics, Inc (SNSE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SNSE, ranked by similarity.
Seasonality analysis for SNSE
Historically the probability of a positive August return for SNSE is 2.33%. April offers the highest probability of a positive month at 67.19%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SNSE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $6.45 | $7.07 | $7.30 | -48.97% |
| Sep 2026 | $7.54 | $9.47 | $10.08 | -31.65% |
| Oct 2026 | $6.03 | $7.00 | $8.81 | -49.48% |
| Nov 2026 | $7.71 | $8.96 | $10.60 | -35.30% |
| Dec 2026 | $7.45 | $7.80 | $8.50 | -43.66% |
In 2026, Faeth Therapeutics, Inc (SNSE) is projected to range from $6.03 to $10.60.
Faeth Therapeutics, Inc 2026 monthly forecast
In Aug 2026, Faeth Therapeutics, Inc is projected to average $7.07, with a low of $6.45 and high of $7.30.
In Sep 2026, Faeth Therapeutics, Inc is projected to average $9.47, with a low of $7.54 and high of $10.08.
In Oct 2026, Faeth Therapeutics, Inc is projected to average $7.00, with a low of $6.03 and high of $8.81.
In Nov 2026, Faeth Therapeutics, Inc is projected to average $8.96, with a low of $7.71 and high of $10.60.
In Dec 2026, Faeth Therapeutics, Inc is projected to average $7.80, with a low of $7.45 and high of $8.50.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.